In A Competitive Landscape, What Gives Xeraya Capital An Edge?
October 2, 202022m 39s
Audio is streamed directly from the publisher (traffic.omny.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Xeraya Capital is the life sciences investment arm of Khazanah Nasional, invested in medical technology and biological sciences. Why did Khazanah choose to invest in this space? And what edge does Xeraya have? We speak to CEO Fares Zahir about this and more.
Image Credit: Billion Photos / Shutterstock.com
See omnystudio.com/listener for privacy information.
Topics
HealthcarePharmaBiotechTelecomITTechnologyCEO/Business leadersHealthlifesciencesmedical technologyXeraya